Last --
Change Today 0.00 / 0.00%
Volume 0.0
UN6A On Other Exchanges
Symbol
Exchange
London
OTC US
OTC US
Xetra
All times are local (Market data is delayed by at least 15 minutes).

united drug plc (UN6A) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
05/15/13
P/E TM
--
Dividend
€0.09
Dividend Yield
--
Current Stock Chart for UNITED DRUG PLC (UN6A)

Related News

No related news articles were found.

united drug plc (UN6A) Related Businessweek News

No Related Businessweek News Found

united drug plc (UN6A) Details

United Drug plc, together with its subsidiaries, offers commercialization solutions to healthcare manufacturers and pharmaceutical retailers in the United Kingdom, Ireland, the Netherlands, Belgium, and the United States. The company’s Healthcare Supply Chain segment provides delivery services of pharmaceuticals and consumer health products to retail and hospital pharmacies; and contract distribution and other services to pharmaceutical, consumer health, and animal health manufacturers. This segment also sells, distributes, and supports consumables and capital equipment to healthcare providers industry and research institutions; and manufactures and distributes various prepared products to fulfill patient prescription requirements of the retail pharmacy and hospital markets. Its Sales, Marketing, and Medical segment offers contract sales outsourcing services; and sales and marketing services, including medical affairs information, patient compliance support, and clinical trials recruitment to pharmaceutical manufacturers, as well as sales force effectiveness training, bespoke event management, and logistical services to the pharmaceutical sector. This segment also provides healthcare communications and consultancy services to pharmaceutical and biotechnology companies. The company’s Packaging and Specialty segment offers primary and secondary packaging solutions; and nurse-led homecare services to the healthcare sector. This segment is also involved in the sale and distribution of vaccines and medical information; and provision of clinical services in the travel field. United Drug plc was founded in 1948 and is based in Dublin, Ireland.

7,000 Employees
Last Reported Date: 01/11/13
Founded in 1948

united drug plc (UN6A) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: €980.0K
Finance Director and Director
Total Annual Compensation: €468.0K
Executive Director and Managing Director of C...
Total Annual Compensation: €533.0K
Executive Director
Total Annual Compensation: €514.0K
Compensation as of Fiscal Year 2012.

united drug plc (UN6A) Key Developments

United Drug plc Announces Unaudited Consolidated Earnings Results for the Six Months Ended March 31, 2013; Declares Interim Dividend, Payable on July 16, 2013; Plans to Open New Office in Shanghai

United Drug plc announced unaudited consolidated earnings results for the six months ended March 31, 2013. For six months, the company announced revenue of EUR 1,017,389,000 compared to EUR 1894,224,000 for the same period a year ago. Operating profit was EUR 24,498,000 compared to EUR 32,598,000 for the same period a year ago. Profit before tax was EUR 17,860,000 compared to EUR 28,119,000 for the same period a year ago. Profit for the period was EUR 13,165,000 compared to EUR 22,954,000 for the same period a year ago. Profit attributable to owners of the parent company was EUR 13,129,000 compared to EUR 23,027,000 for the same period a year ago. Earnings per share, diluted were 5.47 cents compared to 9.62 cents for the same period a year ago. Net cash inflow from operating activities was EUR 55,752,000 compared to EUR 20,373,000 for the same period a year ago. Purchase of property, plant and equipment was EUR 23,923,000 compared to EUR 18,090,000 for the same period a year ago. Earnings adjusted for amortization of intangible assets, acquisition costs and exceptional item was EUR 30,221,000 or 12.58 cents per diluted share compared to EUR 28,225,000 or 11.80 cents per diluted share for the same period a year ago. Net debt as on March 31, 2013 was EUR 220.5 million. The company announced that the board of directors has declared an interim dividend of 2.61 cent per share, a 5% increase on the 2012 interim dividend. The interim dividend is payable to shareholders on the company's register on 17 May 2013 and will be paid on 16 July 2013. A Dividend Reinvestment Plan, which enables shareholders who elect to participate to use their cash dividend to acquire additional shares in the Company, is available in respect of the interim dividend. The company announced global client development has helped facilitate new business wins, which will be further enhanced by the opening of a new office in Shanghai.

United Drug plc, H1 2013 Earnings Call, May 09, 2013

United Drug plc, H1 2013 Earnings Call, May 09, 2013

United Drug Plc Announces Management Changes

United Drug plc announced that Ms. Karen Geoghegan will step down and Mr. Mike Gannon will be appointed as Company Secretary with effect from April 1, 2013. Mr. Mike Gannon is Director of Corporate Services and former Group Financial Controller.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UN6A:GR €0.00 EUR 0.00

UN6A Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cardinal Health Inc $48.06 USD +0.035
Celesio AG €16.32 EUR +0.05
CMIC Holdings Co Ltd ¥2,343 JPY -50.00
EPS Corp/Japan ¥147,700 JPY -4,000.00
Galenica AG SFr.631.50 CHF +4.50
View Industry Companies
 

Industry Analysis

UN6A

Industry Average

Valuation UN6A Industry Range
Price/Earnings 18.5x
Price/Sales 0.4x
Price/Book 1.7x
Price/Cash Flow 18.5x
TEV/Sales 0.1x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNITED DRUG PLC, please visit www.united-drug.ie. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.